MedPath

Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease

Not Applicable
Completed
Conditions
Stable Coronary Heart Disease
Interventions
Dietary Supplement: flavanol-rich drink vs flavanol-free drink
Registration Number
NCT02520466
Lead Sponsor
University of Zurich
Brief Summary

The aim of the present study is to investigate whether the ingestion of a cocoa flavanol-containing drink compared to a flavanol-free drink, improves coronary vasomotion and platelet function in patients with overt coronary artery disease acutely (after 2 hours)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria

Patients with coronary artery disease undergoing elective coronary angiography with or without the need of coronary intervention

  • Age 20 - 80
  • Written obtained informed consent
Read More
Exclusion Criteria
  • Acute ST-elevation myocardial infarction
  • Acute non-ST-elevation myocardial infarction (enzyme positive)
  • Ventricular tachy-arrythmias or AV-Block >I°
  • Renal insufficiency (GFR MDRD < 30ml/min) or liver disease (ALT or AST >150 IU)
  • Pregnancy
  • Known allergy to compounds of cocoa product
  • Known allergy to contrast media
  • Known allergy to nuts
  • Intolerance to coffein and theobromin
  • Acute infectious disease
  • Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn)
  • Participation in another study within the last month
  • Concomitant vitamin supplements and herbal remedies, as well as fruit and tea extracts
  • No study visits ± 1 week before Eastern, Christmas and New Year holyday (altered eating habits)
  • Extreme eating habits (as assessed by a questionnaire)
  • Alcohol or drug abuse
  • Lactose intolerance
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
flavanol-containing drinkflavanol-rich drink vs flavanol-free drinkflavanol-containing drink
flavanol-free drinkflavanol-rich drink vs flavanol-free drinkflavanol-free drink matched for taste and calories
Primary Outcome Measures
NameTimeMethod
coronary endothelial function as assessed as response to cold pressor test2 hours

Primary endpoint will be the improvement in coronary endothelial function in response to cold pressor testing (i.e. % reduction in coronary artery constriction compared to baseline) 2h after ingestion of a cocoa flavanol rich-drink or placebo drink, respectively.

In a subset of patients daily consumption of a flavanol-drink will be assessed and outcomes measured after 3-4 weeks.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Cardiovascular Center Cardiology Univeristy Hospital of Zurich

🇨🇭

Zurich, Switzerland

Universisty Hospital of Zurich, Cardiovascular Center Cardiology

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath